95 related articles for article (PubMed ID: 23198686)
1. Dissecting the carbohydrate specificity of the anti-HIV-1 2G12 antibody by single-molecule force spectroscopy.
Martines E; García I; Marradi M; Padro D; Penadés S
Langmuir; 2012 Dec; 28(51):17726-32. PubMed ID: 23198686
[TBL] [Abstract][Full Text] [Related]
2. Binding of high-mannose-type oligosaccharides and synthetic oligomannose clusters to human antibody 2G12: implications for HIV-1 vaccine design.
Wang LX; Ni J; Singh S; Li H
Chem Biol; 2004 Jan; 11(1):127-34. PubMed ID: 15113002
[TBL] [Abstract][Full Text] [Related]
3. A solution NMR study of the interactions of oligomannosides and the anti-HIV-1 2G12 antibody reveals distinct binding modes for branched ligands.
Enríquez-Navas PM; Marradi M; Padro D; Angulo J; Penadés S
Chemistry; 2011 Feb; 17(5):1547-60. PubMed ID: 21268157
[TBL] [Abstract][Full Text] [Related]
4. Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12.
Pashov A; MacLeod S; Saha R; Perry M; VanCott TC; Kieber-Emmons T
Glycobiology; 2005 Oct; 15(10):994-1001. PubMed ID: 15917430
[TBL] [Abstract][Full Text] [Related]
5. Gold nanoparticles coated with oligomannosides of HIV-1 glycoprotein gp120 mimic the carbohydrate epitope of antibody 2G12.
Marradi M; Di Gianvincenzo P; Enríquez-Navas PM; Martínez-Ávila OM; Chiodo F; Yuste E; Angulo J; Penadés S
J Mol Biol; 2011 Jul; 410(5):798-810. PubMed ID: 21440555
[TBL] [Abstract][Full Text] [Related]
6. STD NMR study of the interactions between antibody 2G12 and synthetic oligomannosides that mimic selected branches of gp120 glycans.
Enríquez-Navas PM; Chiodo F; Marradi M; Angulo J; Penadés S
Chembiochem; 2012 Jun; 13(9):1357-65. PubMed ID: 22628288
[TBL] [Abstract][Full Text] [Related]
7. Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12.
Calarese DA; Lee HK; Huang CY; Best MD; Astronomo RD; Stanfield RL; Katinger H; Burton DR; Wong CH; Wilson IA
Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13372-7. PubMed ID: 16174734
[TBL] [Abstract][Full Text] [Related]
8. Antibody 2G12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the HIV-1 glycan shield if domain exchanged.
Doores KJ; Fulton Z; Huber M; Wilson IA; Burton DR
J Virol; 2010 Oct; 84(20):10690-9. PubMed ID: 20702629
[TBL] [Abstract][Full Text] [Related]
9. A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120.
Astronomo RD; Lee HK; Scanlan CN; Pantophlet R; Huang CY; Wilson IA; Blixt O; Dwek RA; Wong CH; Burton DR
J Virol; 2008 Jul; 82(13):6359-68. PubMed ID: 18434393
[TBL] [Abstract][Full Text] [Related]
10. Assembling different antennas of the gp120 high mannose-type glycans on gold nanoparticles provides superior binding to the anti-HIV antibody 2G12 than the individual antennas.
Chiodo F; Enríquez-Navas PM; Angulo J; Marradi M; Penadés S
Carbohydr Res; 2015 Mar; 405():102-9. PubMed ID: 25573666
[TBL] [Abstract][Full Text] [Related]
11. An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies.
Luallen RJ; Lin J; Fu H; Cai KK; Agrawal C; Mboudjeka I; Lee FH; Montefiori D; Smith DF; Doms RW; Geng Y
J Virol; 2008 Jul; 82(13):6447-57. PubMed ID: 18434410
[TBL] [Abstract][Full Text] [Related]
12. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.
Scanlan CN; Pantophlet R; Wormald MR; Ollmann Saphire E; Stanfield R; Wilson IA; Katinger H; Dwek RA; Rudd PM; Burton DR
J Virol; 2002 Jul; 76(14):7306-21. PubMed ID: 12072529
[TBL] [Abstract][Full Text] [Related]
13. Reactivity-based one-pot synthesis of oligomannoses: defining antigens recognized by 2G12, a broadly neutralizing anti-HIV-1 antibody.
Lee HK; Scanlan CN; Huang CY; Chang AY; Calarese DA; Dwek RA; Rudd PM; Burton DR; Wilson IA; Wong CH
Angew Chem Int Ed Engl; 2004 Feb; 43(8):1000-3. PubMed ID: 14966891
[No Abstract] [Full Text] [Related]
14. N-linked glycan modifications in gp120 of human immunodeficiency virus type 1 subtype C render partial sensitivity to 2G12 antibody neutralization.
Gray ES; Moore PL; Pantophlet RA; Morris L
J Virol; 2007 Oct; 81(19):10769-76. PubMed ID: 17634239
[TBL] [Abstract][Full Text] [Related]
15. Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12.
Huskens D; Van Laethem K; Vermeire K; Balzarini J; Schols D
Virology; 2007 Apr; 360(2):294-304. PubMed ID: 17123566
[TBL] [Abstract][Full Text] [Related]
16. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.
Sanders RW; Venturi M; Schiffner L; Kalyanaraman R; Katinger H; Lloyd KO; Kwong PD; Moore JP
J Virol; 2002 Jul; 76(14):7293-305. PubMed ID: 12072528
[TBL] [Abstract][Full Text] [Related]
17. 2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies.
Doores KJ; Huber M; Le KM; Wang SK; Doyle-Cooper C; Cooper A; Pantophlet R; Wong CH; Nemazee D; Burton DR
J Virol; 2013 Feb; 87(4):2234-41. PubMed ID: 23221565
[TBL] [Abstract][Full Text] [Related]
18. A yeast glycoprotein shows high-affinity binding to the broadly neutralizing human immunodeficiency virus antibody 2G12 and inhibits gp120 interactions with 2G12 and DC-SIGN.
Luallen RJ; Fu H; Agrawal-Gamse C; Mboudjeka I; Huang W; Lee FH; Wang LX; Doms RW; Geng Y
J Virol; 2009 May; 83(10):4861-70. PubMed ID: 19264785
[TBL] [Abstract][Full Text] [Related]
19. A bacterial lipooligosaccharide that naturally mimics the epitope of the HIV-neutralizing antibody 2G12 as a template for vaccine design.
Clark BE; Auyeung K; Fregolino E; Parrilli M; Lanzetta R; De Castro C; Pantophlet R
Chem Biol; 2012 Feb; 19(2):254-63. PubMed ID: 22365608
[TBL] [Abstract][Full Text] [Related]
20. Polyepitope protein incorporated the HIV-1 mimotope recognized by monoclonal antibody 2G12.
Karpenko LI; Scherbakova NS; Chikaev AN; Tumanova OY; Lebedev LR; Shalamova LA; Pyankova OG; Ryzhikov AB; Ilyichev AA
Mol Immunol; 2012 Apr; 50(4):193-9. PubMed ID: 22341130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
